BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31865649)

  • 1. Micafungin as antifungal prophylaxis in non-transplanted haemotological patients.
    Villaescusa T; Vázquez L; Bergua JM; García J; Romero A; Olave MT; García Belmonte D; Queipo de Llano MP;
    Rev Esp Quimioter; 2020 Feb; 33(1):44-48. PubMed ID: 31865649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micafungin prophylaxis for acute leukemia patients undergoing induction chemotherapy.
    Park H; Youk J; Shin DY; Hong J; Kim I; Kim NJ; Lee JO; Bang SM; Yoon SS; Park WB; Koh Y
    BMC Cancer; 2019 Apr; 19(1):358. PubMed ID: 30991992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary antifungal prophylaxis with micafungin in patients with haematological malignancies: real-life data from a retrospective single-centre observational study.
    Nachbaur D; Angelova O; Orth-Höller D; Ditlbacher A; Lackner M; Auberger J; Lass-Flörl C
    Eur J Haematol; 2015 Mar; 94(3):258-64. PubMed ID: 25082655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of micafungin as an empirical therapy for invasive fungal infections in patients with hematologic disorders: a multicenter, prospective study.
    Yamaguchi M; Kurokawa T; Ishiyama K; Aoki G; Ueda M; Matano S; Takami A; Yamazaki H; Sawazaki A; Yamauchi H; Yoshida T; Nakao S
    Ann Hematol; 2011 Oct; 90(10):1209-17. PubMed ID: 21695388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Micafungin twice-a-week for prophylaxis of invasive Aspergillus infections in children with acute lymphoblastic leukaemia: A controlled cohort study.
    Bury D; Wolfs TFW; Muilwijk EW; Fiocco M; Pieters R; Brüggemann RJ; Tissing WJE
    Int J Antimicrob Agents; 2024 Jan; 63(1):107058. PubMed ID: 38081549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of micafungin as antifungal prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) in Spain (GETH-MIC).
    López-Sánchez C; Valcárcel D; Gómez V; López-Jiménez J; Serrano D; Rubio V; Solano C; Vázquez L; Ruiz I;
    Rev Esp Quimioter; 2020 Apr; 33(2):110-115. PubMed ID: 32056418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients.
    Park S; Kim K; Jang JH; Kim SJ; Kim WS; Chung DR; Kang CI; Peck KR; Jung CW
    J Infect; 2016 Nov; 73(5):496-505. PubMed ID: 27394404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Micafungin as primary antifungal prophylaxis in patients presenting with acute myeloid leukemia.
    Venton G; Adam H; Colle J; Labiad Y; Mercier C; Ivanov V; Suchon P; Fanciullino R; Farnault L; Costello R
    Med Mal Infect; 2016 Jun; 46(4):226-9. PubMed ID: 27126350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Micafungin for the treatment of invasive aspergillosis.
    Enoch DA; Idris SF; Aliyu SH; Micallef C; Sule O; Karas JA
    J Infect; 2014 Jun; 68(6):507-26. PubMed ID: 24480373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary antifungal prophylaxis with micafungin after allogeneic hematopoietic stem cell transplantation: a monocentric prospective study.
    Xhaard A; Porcher R; Bergeron A; Alanio A; Touratier S; Bretagne S; de Margerie-Mellon C; Sicre de Fontbrune F; Itzykson R; Coman T; Robin M; Cabannes-Hamy A; Socié G; Peffault de Latour R
    Ann Hematol; 2019 Apr; 98(4):1033-1035. PubMed ID: 30353389
    [No Abstract]   [Full Text] [Related]  

  • 11. Breakthrough Invasive Fungal Infections in Patients with Acute Myeloid Leukemia.
    Wasylyshyn A; Linder KA; Castillo CG; Zhou S; Kauffman CA; Miceli MH
    Mycopathologia; 2020 Apr; 185(2):299-306. PubMed ID: 31939052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of micafungin for invasive candida infections: a meta-analysis of randomized controlled trials.
    Chen Q; Lin MH; Chen ML; Liu ZY; Chai D; Wang R
    Chin Med J (Engl); 2012 Jan; 125(2):345-51. PubMed ID: 22340571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Micafungin for Candida infections in Slovenia and Romania: A multicenter, observational, prospective study.
    Zver S; Avcin S; Bedreag O; Bizilj S; Ecrulj V; Jazbec J; Puconja N; Stanic R; Jereb M
    J Infect Dev Ctries; 2021 Jun; 15(6):877-888. PubMed ID: 34242200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Micafungin: a review of its use in adults for the treatment of invasive and oesophageal candidiasis, and as prophylaxis against Candida infections.
    Cross SA; Scott LJ
    Drugs; 2008; 68(15):2225-55. PubMed ID: 18840009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of micafungin as an empirical antifungal agent for febrile neutropenic patients with hematological diseases.
    Park JS; Kim DH; Choi CW; Jeong SH; Choi JH; Kim K; Kim SJ; Jung CW; Yang DH; Jang JH
    Acta Haematol; 2010; 124(2):92-7. PubMed ID: 20664196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Micafungin: A Review in the Prophylaxis and Treatment of Invasive Candida Infections in Paediatric Patients.
    Scott LJ
    Paediatr Drugs; 2017 Feb; 19(1):81-90. PubMed ID: 28083856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential systematic anti-mold prophylaxis with micafungin and voriconazole results in very low incidence of invasive mold infections in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Rosillo C; Avila AM; Huang YT; Devlin S; Cho C; Montoro J; Maloy MA; Papanicolaou GA; Barba P; Perales MA
    Transpl Infect Dis; 2018 Aug; 20(4):e12897. PubMed ID: 29668073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe infections in children with acute leukemia undergoing intensive chemotherapy can successfully be prevented by ciprofloxacin, voriconazole, or micafungin prophylaxis.
    Yeh TC; Liu HC; Hou JY; Chen KH; Huang TH; Chang CY; Liang DC
    Cancer; 2014 Apr; 120(8):1255-62. PubMed ID: 24415457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Micafungin as antifungal prophylaxis in recipients of allogeneic hematopoietic stem cell transplantation: results of different dosage levels in clinical practice.
    Langebrake C; Rohde H; Lellek H; Wolschke C; Kröger NM
    Clin Transplant; 2014 Mar; 28(3):286-91. PubMed ID: 24479680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Micafungin.
    Jarvis B; Figgitt DP; Scott LJ
    Drugs; 2004; 64(9):969-82; discussion 983-4. PubMed ID: 15101786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.